The Ebola virus continues to march across West Africa, with the latest numbers putting the death toll at over 2,000. Countries around the world are scrambling to develop a vaccine, but it could be months before it reaches those who need it most. This hour we'll take a look at the science and the business of producing vaccines.
Guests:
Todd Frankel, reporter for the Washington Post
Dr. Darria Long-Gillespie, executive vice president at Sharecare, assistant professor at the Emory University School of Medicine
Ken Kaitin, director of The Center for Drug Development at Tufts University